Cargando…

The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells

Cervical liquid-based cytology plays an important role in the diagnosis of cervical squamous intraepithelial lesion (SIL). However, cytological evaluation alone has a relatively low sensitive. To overcome this problem, HPV DNA testing or HPV DNA combined with cytology has been applied. HPV DNA testi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ming-Zhe, Wang, Shiyu, Zheng, Min, Tian, Li-Xiang, Wu, Xin, Guo, Ke-Jun, Zhang, YI, Wu, Guang-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362523/ https://www.ncbi.nlm.nih.gov/pubmed/30545241 http://dx.doi.org/10.1177/0963689718817478

Ejemplares similares

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System
por: Alrajjal, Ahmed, et al.
Publicado: (2021)

Predictive value of p16(INK4a), Ki-67 and ProExC immuno-qualitative features in LSIL progression into HSIL
por: Ding, Ling, et al.
Publicado: (2020)

Additional role of ECC in the detection and treatment of cervical HSIL
por: Sijing, Li, et al.
Publicado: (2023)

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
por: Bhuyan, Prakash K., et al.
Publicado: (2020)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

Immunostaining of p16(INK4a)/Ki-67 and L1 Capsid Protein on Liquid-based Cytology Specimens Obtained from ASC-H and LSIL-H Cases
por: Byun, Seung Won, et al.
Publicado: (2013)

Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: Cao, Limei, et al.
Publicado: (2022)

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men
por: Machalek, Dorothy A., et al.
Publicado: (2016)

Cervicoscopy and Microcolposcopy in the Evaluation of Squamo Columnar Junction and Cervical Canal in LSIL Patients with Inadequate or Negative Colposcopy
por: Valli, Edoardo, et al.
Publicado: (2013)

Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
por: Gilles, Christine, et al.
Publicado: (2021)

Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
por: Ki, Eun Young, et al.
Publicado: (2019)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

Cytological, Colposcopic and Pathohistological Correlation of HSIL and ASC H Findings
por: Jahic, Mahira, et al.
Publicado: (2020)

Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors
por: Das, Diya, et al.
Publicado: (2018)

Diagnostic Three Slides Pap Test Compared to Punch Biopsy and Endocervical Curettage in Confirmed HSIL+ Diagnosis
por: Rubeša-Mihaljević, Roberta, et al.
Publicado: (2021)

Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Diagnostic Value of p16/Ki67 Dual Immunostaining for Anal Intraepithelial Neoplasia: A Meta-Analysis
por: Chen, Cheng-Chieh, et al.
Publicado: (2020)

Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2+
por: Martí, Cristina, et al.
Publicado: (2021)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Diagnostic Performance of p16/Ki-67 Dual Immunostaining at Different Number of Positive Cells in Cervical Smears in Women Referred for Colposcopy
por: Gajsek, Ursula Salobir, et al.
Publicado: (2021)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study
por: Rashed, Mona M, et al.
Publicado: (2011)

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
por: Ghelardi, Alessandro, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEP
por: Huang, Guanxiang, et al.
Publicado: (2023)

The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization
por: Chen, Jun-yu, et al.
Publicado: (2018)

Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis
por: Sezer, Engin, et al.
Publicado: (2015)

Diagnostic Utility of Galactose-Deficient Immunoglobulin A1 Immunostaining in the Differentiation of Lupus Nephritis and Immunoglobulin A Nephropathy
por: Bu, Lihong, et al.
Publicado: (2021)

Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

Diagnostic Utility of the PD-L1 Immunostaining in Biopsy Specimens of Patients with Biliary Tract Neoplasms
por: Matsumoto, Kazuyuki, et al.
Publicado: (2022)

HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China
por: Zheng, Baowen, et al.
Publicado: (2017)

Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3
por: del Pino, Marta, et al.
Publicado: (2021)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Diagnostic Accuracy of p16(INK4a)/Ki-67 Dual Immunostaining for Detection of High-Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia
por: Kakaliashvili-Dzagnidze, Sopio, et al.
Publicado: (2023)

p16 immunostaining as a predictor of anal and cervical dysplasia in women attending a sexually transmitted infection clinic
por: Pandhi, Deepika, et al.
Publicado: (2016)

Re-evaluation of Negative Cone Biopsy Results with Ki-67 and p16 Immunostaining following Positive Cervical Biopsy
por: Sari Aslani, Fatemeh, et al.
Publicado: (2020)

Predictive Role of the p16 Immunostaining Pattern in Atypical Cervical Biopsies with Less Common High Risk HPV Genotypes
por: Cabibi, Daniela, et al.
Publicado: (2021)

Limitations on the Detection Rate of High-Risk HPV by Hybrid Capture 2 Methodology in High Grade Intraepithelial (HSIL) or Atypical Squamous Cells-Cannot Exclude HSIL (ASC-H) Cytological Lesions with Proved CIN2+
por: Noël, Jean-Christophe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e4jhhg7k69f1mvdc2qrsutuvjp